Lifeist Portfolio Company Mikra Adds Olympic Medalists as Brand Ambassadors
April 13 2022 - 7:00AM
Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV:
LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF), a health-tech
company that leverages advancements in science and technology to
build breakthrough companies that transform human wellness, today
announced its wholly owned U.S. subsidiary, Mikra Cellular Sciences
Inc. (“Mikra”), has engaged Olympic medalists Ashley Wagner and
Cullen Jones as Brand Ambassadors.
Ashley Wagner is a bronze medalist in figure
skating at the 2014 Sochi Winter Olympics and a silver medalist at
the 2016 World Championships. Since Michelle Kwan in 1999, Wagner
was the first U.S. senior ladies figure skater to win three
national championships (2012, 2013 and 2015).
Cullen Jones is a gold medalist in swimming at
the 2008 Olympic Games in the 4x100m freestyle, and won two silvers
(4x100m freestyle relay and 50m freestyle) and a gold in the 4x100m
medley relay at the 2012 Olympic Games. He also won two gold medals
and one silver medal at the swimming world championships.
“To complement our development deal with
baseball hero Jose Bautista, Mikra continues to assemble a roster
of athletic role models and amazing humans to support the launch of
Mikra and push our mission of increasing the world’s healthspan
forward,” said Faraaz Jamal, COO of Lifeist and CEO of Mikra. “Both
Ashley and Cullen are inspirations and trailblazers, and we are
privileged that they are part of the Mikra family. Together, we
plan to help humans around the world enjoy better cellular
health.”“Mikra is a centerpiece of Lifeist's wellness mission to
improve human health, and I couldn't be more encouraged with the
path that it is on,” said Meni Morim, CEO of Lifeist. “After
recently introducing its first breakthrough product, CELLF, Faraaz
and team are continuing to build the ecosystem around Mikra with
these world class athletes. We are just getting started as we go
after the massive nutraceuticals market which is worth over $100
billion dollars in the U.S. alone.”
About Lifeist Wellness Inc.
Sitting at the forefront of the post-pandemic
wellness revolution, Lifeist leverages advancements in science and
technology to build breakthrough companies that transform human
wellness. Portfolio business units include: CannMart, which
operates a B2B wholesale distribution business facilitating
recreational cannabis sales to Canadian provincial government
control boards; CannMart Labs, a BHO extraction facility for the
production of high margin cannabis 2.0 products; the CannMart.com
marketplace, which provides U.S. customers with access to
hemp-derived CBD and smoking accessories; Australian Vapes, the
country’s largest online retailer of vaporizers and accessories;
Findify, a leading AI-powered search and discovery platform; and
Mikra, a biosciences and consumer wellness company seeking to
develop innovative therapies for cellular health.
Information on Lifeist and its businesses can be
accessed through the links below:
www.lifeist.comwww.cannmart.comwww.australianvaporizers.com.auwww.wearemikra.com
Contacts
Lifeist Wellness Inc.Meni Morim, CEOMatt
Chesler, CFA, Investor RelationsPh: 647-362-0390Email:
ir@lifeist.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release or has in any way approved
or disapproved of the contents of this press release.
Forward Looking Information
This news release contains “forward-looking
information” within the meaning of applicable securities laws. All
statements contained herein that are not historical in nature
contain forward-looking information. Forward-looking information
can be identified by words or phrases such as “may”, “expect”,
“likely”, “should”, “would”, “plan”, “anticipate”, “intend”,
“potential”, “proposed”, “estimate”, “believe” or the negative of
these terms, or other similar words, expressions and grammatical
variations thereof, or statements that certain events or conditions
“may” or “will” happen.
The forward-looking information contained
herein, including, without limitation, statements related to
Mikra’s ongoing and future development plans in the nutraceuticals
market are made as of the date of this press release and is based
on assumptions management believed to be reasonable at the time
such statements were made, including, without limitation, brand
ambassadors will be an integral part of Mikra’s successful
development, its expectation that the nutraceutical market will
develop as currently anticipated, the nutraceutical market will
continue to be a multi-billion dollar high-margin market, the
introduction of new products and brands will generate additional
revenue, expectations that CELLF and other cellular health products
and accessories to be developed by the Company will gain market
acceptance along with the expansion of the market for nutraceutical
products, as well as other considerations that are believed to be
appropriate in the circumstances. While we consider these
assumptions to be reasonable based on information currently
available to management, there is no assurance that such
expectations will prove to be correct. By its nature,
forward-looking information is subject to inherent risks and
uncertainties that may be general or specific and which give rise
to the possibility that expectations, forecasts, predictions,
projections or conclusions will not prove to be accurate, that
assumptions may not be correct and that objectives, strategic goals
and priorities will not be achieved. A variety of factors,
including known and unknown risks, many of which are beyond our
control, could cause actual results to differ materially from the
forward-looking information in this press release. Such factors
include, without limitation: the inability of the Company to
develop Mikra’s business as anticipated, unanticipated changes to
current regulations that would adversely impact Mikra’s business,
unforeseen developments that would delay Mikra’s ability to sell
CELLF or any other nutraceutical products, the risk that the
expected demand for nutraceutical products in general and those of
Mikra in particular does not develop as anticipated and risks
relating to the Company’s ability to execute its business strategy
and the benefits realizable therefrom. Additional risk factors can
also be found in the Company’s current MD&A and annual
information form, both of which have been filed under the Company’s
SEDAR profile at www.sedar.com. Readers are cautioned not to put
undue reliance on forward-looking information. The Company
undertakes no obligation to update or revise any forward-looking
information, whether as a result of new information, future events
or otherwise, except as required by applicable law. Forward-looking
statements contained in this news release are expressly qualified
by this cautionary statement.
Source: Lifeist Wellness Inc.
Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/63fc97a9-aac1-41d1-a025-107f9936031d
https://www.globenewswire.com/NewsRoom/AttachmentNg/ecd17e83-9997-4c9b-bf0b-4f501dfe5983
Lifeist Wellness (TSXV:LFST)
Historical Stock Chart
From Mar 2024 to Apr 2024
Lifeist Wellness (TSXV:LFST)
Historical Stock Chart
From Apr 2023 to Apr 2024